Home LiteratureArticle Details
PMID: 8141324 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Synergistic effects of angiotensin and adenosine in the renal microvasculature.

The American journal of physiology ·Vol. 266 ·No. 2 Pt 2 ·1994-02-00 ·Pages F227-39

Weihprecht H, Lorenz JN, Briggs JP, Schnermann J

Abstract

Experiments were performed in the in situ kidney of rats and in isolated afferent arterioles of the rabbit to study the interaction between angiotensin II and adenosine in producing afferent arteriolar vasoconstriction. In the intact rat kidney, we observed that 1) peritubular infusion of the adenosine1-receptor blocker 8-cyclopentyl-1,3-dipropylxanthine (CPX, 10(-4) M) blocked the fall in stop-flow pressure (PSF) induced by angiotensin II (5 x 10(-7) M) but not that caused by vasopressin (10(-5) M) or norepinephrine (10(-5) M), 2) peritubular infusion of saralasin (5 x 10(-5) M) attenuated the fall in PSF caused by N6-cyclohexyladenosine (CHA, 10(-5) M) 3) the fall in PSF following luminal application of CHA (10(-5) M) was reduced in angiotensin II-depleted states (volume expansion and converting enzyme inhibition) and this could be reversed by infusion of low doses of angiotensin II, and 4) the reduction in PSF in response to luminal infusion of CHA was augmented in a greater-than-additive fashion when angiotensin was simultaneously administered at low intravenous infusion rates. In isolated afferent arterioles of the rabbit, we noted that 1) addition of 10(-5) M CPX to the bath significantly blunted the constrictor effect of angiotensin II (10(-8) M), 2) presence of the converting enzyme inhibitor quinaprilate (10(-7) M) caused a right shift in the constrictor-response curve to increasing concentrations of CHA (10(-9)-10(-5) M) but 10(-5) M saralasin did not affect vasoconstriction caused by 10(-6) M adenosine, 3) simultaneous administration of submaximal constrictor doses of angiotensin II (10(-10) M) and adenosine (10(-6) M) produced vasoconstriction that was greater than additive, and 4) 10(-5) M CHA and angiotensin II (10(-7) M) constricted afferent arterioles after removal of the glomerulus, whereas either agent alone had no constrictor effect in this preparation. Our results suggest that adenosine and angiotensin cooperate in a mutually dependent and synergistic fashion in producing afferent arteriolar vasoconstriction.

MeSH Terms
Adenosine/pharmacology Analysis of Variance Angiotensin II/pharmacology Animals Antihypertensive Agents/pharmacology Arterioles/cytology,drug effects,physiology Blood Pressure Drug Synergism In Vitro Techniques Isoquinolines/pharmacology Kidney/blood supply Male Microcirculation/drug effects,physiology Muscle, Smooth, Vascular/cytology,drug effects,physiology Purinergic P1 Receptor Antagonists Quinapril Rabbits Rats Rats, Sprague-Dawley Renal Circulation/drug effects Saralasin/pharmacology Tetrahydroisoquinolines Theophylline/analogs & derivatives,pharmacology Vasoconstriction/drug effects
Chemicals
Antihypertensive Agents Isoquinolines Purinergic P1 Receptor Antagonists Tetrahydroisoquinolines Angiotensin II 8-cyclopentyl-1,3-dimethylxanthine Theophylline Saralasin Adenosine Quinapril
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Weihprecht H
Department of Physiology, University of Michigan, Ann Arbor 48104.
Lorenz J N
Briggs J P
Schnermann J
Article Info
Journal
The American journal of physiology
Abbr.
Am J Physiol
ISSN
0002-9513
Published
1994-02-00
Pages
F227-39
Language
English
Region
United States
NLM ID
0370511
Subset
IM
Grants
NIDDK NIH HHS · DK-37448 · United States
NIDDK NIH HHS · DK-39255 · United States
NIDDK NIH HHS · DK-40042 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]